Anthem Blue Cross and Blue Shield will cover C2N Diagnostics’ PrecivityAD2 blood test for Alzheimer’s disease evaluation starting Oct 1, 2026, expanding access to the diagnostic tool for adults with cognitive decline.
The new service supports transplantation medicine for 13 million people across Northern California and Northern Nevada.
A new position statement warns that albumin-adjusted calcium formulas are unreliable and may lead to patient misclassification.
Early results indicate the process could reduce sample preparation time by approximately 40% to 50%, while improving consistency by removing variability linked to staining conditions.
The funding will support manufacturing and commercial partnerships for a system that analyzes multiple protein targets in less than two hours.
Research suggests that only 12% of men receiving testosterone prescriptions underwent appropriate testing.
Research suggests new sequencing technologies can help labs move from tissue-level averages to cell-specific testing for precision exercise medicine.
The expanded panel adds 27 HLA-DQ antigens and heterodimer combinations to support more comprehensive antibody assessment in transplant matching and post-transplant monitoring.
HerAnova Lifesciences presented validation data for HerResolve, a blood-based endometriosis test, showing 94.4% accuracy and detection of cases missed by imaging.
The noninvasive method uses paper spray and mass spectrometry to identify disease biomarkers in less than 30 seconds.
The Fleming Initiative and Cepheid have launched a 30-month study in England to compare rapid molecular and traditional culture screening for drug-resistant carbapenemase-producing Enterobacterales in hospital settings.
The transaction includes subsidiaries in the United States, Sweden, and Australia to expand transplantation diagnostic offerings.
The cobas liat system delivers PCR results in 15 minutes, detecting and differentiating between three Bordetella pathogens including whooping cough.
The screening tool identifies specific molecules produced by gut bacteria to distinguish children with autism from typically developing peers.